First in a New Class of Antiepileptic Drugs (AEDs) for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS) or Dravet Syndrome in Patients 2 Years and Older1

Introducing the first and only FDA-approved prescription cannabidiol1